CASI Pharma (CASI) Reports Q2 Loss of $0.06/Share

CASI Pharma (NASDAQ: CASI) reported Q2 EPS of ($0.06), versus ($0.06) reported last year. Revenue for the quarter came in at $24 thousand, versus $0 reported last year.

For earnings history and earnings-related data on CASI Pharma (CASI) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• FedEx (FDX) Tops Q4 EPS by 39c, Beats on Revenue; Offers FY27 EPS Guidance
• Stifel Canada Starts BlackBerry (BB) at Buy